Endoscopic management of high-grade dysplasia and intramucosal carcinoma: experience in a large academic medical center
- Kyle A. PerryAffiliated withDivision of General and Gastrointestinal Surgery, The Ohio State University Email author
- , Jon P. WalkerAffiliated withDivision of Gastroenterology, The Ohio State University
- , Mario SalazarAffiliated withDivision of General and Gastrointestinal Surgery, The Ohio State University
- , Andrew SuzoAffiliated withDivision of General and Gastrointestinal Surgery, The Ohio State University
- , Jeffrey W. HazeyAffiliated withDivision of General and Gastrointestinal Surgery, The Ohio State University
- , W. Scott MelvinAffiliated withDivision of General and Gastrointestinal Surgery, The Ohio State University
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Esophagectomy has been the standard treatment for Barrett’s esophagus (BE) with high-grade dysplasia (HGD) and intramucosal cancer (IMC). Recently, endoscopic mucosal resection (EMR) and radiofrequency ablation (RFA) have become the preferred treatment for these patients in some centers. We report a single institution series of patients undergoing endoscopic management of HGD and IMC.
Nineteen patients underwent endoscopic treatment for HGD or IMC between 2009 and 2012. The primary outcome measure was progression of BE necessitating esophagectomy. Secondary outcomes included complete eradication of intestinal metaplasia (CE-IM), complete eradication of dysplasia (CE-D), recurrence or progression of BE or dysplasia, and complications. Patients were followed for a median follow-up interval of 19 months following completion of RFA treatment.
Three patients (16 %) had a presenting diagnosis of IMC, and 16 (84 %) were treated for HGD. Twelve (63 %) had long-segment BE; the median length of BE was 5 cm. Ten (53 %) patients underwent EMR prior to RFA. CE-D was achieved in 88 % of patients, and CE-IM was achieved in 65 % of patients. A median of 2 (1–7) treatments were required, and there were no immediate post-procedure complications. Two patients developed recurrent dysplasia following complete eradication of BE, and each case was successfully managed with repeat RFA. Three patients (16 %) required esophagectomy within 6 months following RFA. A complete surgical resection was achieved in each case, and none of the patients developed lymph node metastases.
Complete eradication of HGD and IMC can be achieved via endoscopic therapy, thus avoiding esophagectomy in the majority of patients. However, a subset of patients will fail this treatment approach and will require surgical resection. With aggressive endoscopic treatment and surveillance, these patients can be identified at an early stage while curative resection is still possible.
KeywordsBarrett’s esophagus Esophageal cancer High-grade dysplasia Endoscopic mucosal resection Radiofrequency ablation Therapeutic endoscopy
- Endoscopic management of high-grade dysplasia and intramucosal carcinoma: experience in a large academic medical center
Volume 28, Issue 3 , pp 777-782
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Barrett’s esophagus
- Esophageal cancer
- High-grade dysplasia
- Endoscopic mucosal resection
- Radiofrequency ablation
- Therapeutic endoscopy
- Industry Sectors
- Author Affiliations
- 1. Division of General and Gastrointestinal Surgery, The Ohio State University, N729 Doan Hall, 410 W. 10th Ave., Columbus, OH, 43210, USA
- 2. Division of Gastroenterology, The Ohio State University, Columbus, OH, USA